Skip to main content
. 2020 Dec 31;16(12):e1009268. doi: 10.1371/journal.pgen.1009268

Fig 3. Maps with the distribution of the number of pfdhfr/pfdhps mutations (outer pie chart), pfgch1 amplifications (inner pie chart) and sulfadoxine-pyrimethamine (SP) usage (shading of country)).

Fig 3

A. Africa, B. South(east) Asia.